Camptothecin and its derivatives: Advancements, mechanisms and clinical potential in cancer therapy Madhu KamleShikha PandhiJavad Sharifi-Rad Review Article 09 October 2024 Article: 263
Regulation of autophagy by non-coding RNAs in human glioblastoma Mehran MolavandNiloufar EbrahimnezhadeMaryam Majidinia Review Article 07 October 2024 Article: 260
Comparative evaluation of anticancer potential of Spilanthes paniculata leaf and flower essential oil using annexin V and orosphere formation in oral cancer cell line Soumya Subhashree SatapathyRuchi BhuyanSanat Kumar Bhuyan Original Paper 05 October 2024 Article: 259
DDX3X dynamics, glioblastoma's genetic landscape, therapeutic advances, and autophagic interplay Arpit SharmaShruti S. RautAbha Mishra Review Article 05 October 2024 Article: 258
The impact of Trifolium pratense extract on apoptosis and autophagy in NALM-6 cells: implications for B-ALL intervention Vida Shirani AslHassan RafieemehrGholamhossein Tamaddon Original Paper 01 October 2024 Article: 257
Letter to the editor: Comment on “Citalopram, an antipsychotic agent, induces G1/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells” K. Anbarasu Letter to the Editor 01 October 2024 Article: 256
Unraveling the role of EPHA2 in regulating migration and immunomodulation processes in cervical cancer: exploring the synergic effect of 17β-estradiol on cancer progression P. P. MubthasimaAnbarasu Kannan Original Paper 01 October 2024 Article: 255
Centromeres in cancer: Unraveling the link between chromosomal instability and tumorigenesis Mohsen Karami FathAhmad NazariMohsen Nabi Afjadi Review Article 01 October 2024 Article: 254
Gamma-butyrobetaine hydroxylase (BBOX1) exerts suppressive effects on HepG2 hepatoblastoma cells Yuling ZhanXiang DongYu Gao Original Paper 27 September 2024 Article: 253
Personalized treatment approach for HER2-positive metastatic breast cancer Prashant PandeyRishabh ChaudharyP. S. Rajinikanth Review Article 25 September 2024 Article: 252
Analysis of the mechanisms underlying the anticancer and biological activity of retinoic acid and chitosan nanoparticles containing retinoic acid Murat Dogan Original Paper 25 September 2024 Article: 251
The role of molecular biomarkers in recurrent glioblastoma trials: an assessment of the current trial landscape of genome-driven oncology Mark P. van OpijnenFilip Y. F. de VosMarike L. D. Broekman Original Paper Open access 24 September 2024 Article: 250
Vaccine-based therapeutic interventions in lung cancer management: A recent perspective Dhruv Sanjay GuptaDaksh Sanjay GuptaHardeep Singh Tuli Review 24 September 2024 Article: 249
Comment on “gemcitabine, PI3kinase-Akt pathway inhibition and radiation in human glioma cell lines” by M.S. Elnaggar et al.1 M. B. BalajiNeha BrahmaS. Vimal Letter to the Editor 23 September 2024 Article: 248
Letter to the editor for the article “How mitochondrial dynamics imbalance affects the progression of breast cancer: a mini review” Yu ZhangLexin WangHao Chi Letter to the Editor 23 September 2024 Article: 247
Comment on “2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α” Hethesh ChellapandianSivakamavalli Jeyachandran Editorial 23 September 2024 Article: 246
Incidence of lymphedema related to various cancers Marie-Eve LetellierMarize IbrahimGeneviève Chaput Review Open access 17 September 2024 Article: 245
The Sirt1/Nrf2 pathway is a key factor for drug therapy in chemotherapy-induced cardiotoxicity: a Mini-Review Suleiman Ibrahim Shelash MohammadAsokan VasudevanAhmed Hussein Zwamel Review Article 11 September 2024 Article: 244
Lipid metabolism reprogramming in renal cell carcinomas Mustafa Khalid AbduljabbarMohammed MerzaBenien C. Gabel Review 06 September 2024 Article: 243
Turning the tide: pembrolizumab’s triumph in adjuvant RCC therapy Fouad AttiehMarc BoutrosMervat Mahrous Review 05 September 2024 Article: 242
Current diagnostic and quantitative techniques in the field of lymphedema management: a critical review Mary VargoMelissa AldrichAndrea Cheville Review Open access 05 September 2024 Article: 241
The role of IL-22 in cancer Zachary E. HunzekerLei ZhaoYujiang Fang Review 05 September 2024 Article: 240
Advances in immunotoxin engineering: precision therapeutic strategies in modern oncology Akbar OghalaieMahmoud Eshagh HosseiniFatemeh Kazemi-Lomedasht Review 04 September 2024 Article: 239
How mitochondrial dynamics imbalance affects the progression of breast cancer:a mini review Jingwen KuangHao LiuPengcheng Xu Review Open access 01 September 2024 Article: 238
Letter to the editor: comment on “Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment” Murali Santhoshkumar Comment 30 August 2024 Article: 237
Letter to the editor: comment on “Chitosan-loaded piperlongumine nanoparticles and kaempferol enhance the anti-cancer action of doxorubicin in targeting of Ehrlich solid adenocarcinoma: in vivo and in silico modeling study” Adane Desta GonemoAjay Prakash PasupullaMurali Santhoshkumar Comment 29 August 2024 Article: 235
The treatment landscape of triple-negative breast cancer Yi HuChen WangQiong Yang Review Article 29 August 2024 Article: 236
Letter to the editor: Comment on “Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment” Ramya RajendiranMurali Santhoshkumar Comment 23 August 2024 Article: 234
The potential of lenvatinib in breast cancer therapy Yuefeng ShangTong LiuWenjing Wang Review 22 August 2024 Article: 233
2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α Yasmin M. AttiaHamada Ahmed MokhlisMarwa Sharaky Original Paper Open access 21 August 2024 Article: 232
Immunomodulation aspects of gut microbiome-related interventional strategies in colorectal cancer Makan CheraghpourNayeralsadat FatemiLuis G. Bermúdez-Humarán Review 20 August 2024 Article: 231
A new therapeutic strategy for luminal A-breast cancer treatment: vulpinic acid as an anti-neoplastic agent induces ferroptosis and apoptosis mechanisms Ayşe Hale AlkanMine EnsoyDemet Cansaran-Duman Original Paper 19 August 2024 Article: 229
2023 ACS – LANA lymphedema summit forward momentum; future steps in lymphedema management Elizabeth CampioneDavid Doubblestein Editorial 19 August 2024 Article: 230
Moscatilin, a potential therapeutic agent for cancer treatment: insights into molecular mechanisms and clinical prospects Rita Silva-ReisVera L. M. SilvaJavad Sharifi-Rad Review Article 17 August 2024 Article: 228
Cancer/testis antigen expression and co-expression patterns in gastroesophageal adenocarcinoma Sukumar KalvapudiAkhil Goud PachimatlaSarbajit Mukherjee Original Paper Open access 14 August 2024 Article: 227
Therapeutic response and safety of radioligand therapy with 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer patients Wardah AshfaqKhurram RehmanMuhammad Numair Younis Original Paper 13 August 2024 Article: 226
Letters to editor regarding the article “P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway” K. L. G. AfeezaS. BalachandranE. Dilipan Editorial 13 August 2024 Article: 225
Diverse roles of aldolase enzymes in cancer development, drug resistance and therapeutic approaches as moonlighting enzymes Fan TangQingyang Cui Review 09 August 2024 Article: 224
Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review Ehsan MehrtabarAmirreza KhalajiMehdi Soleymani-Goloujeh Review 09 August 2024 Article: 222
Unveiling the potency of FDA-approved oxidopamine HBr for cervical cancer regulation and replication proteins Nawal HelmiAbdullah HamadiMisbahuddin M. Rafeeq Original Paper 09 August 2024 Article: 223
Emerging roles of the chromatin remodeler MORC2 in cancer metabolism Bibhukalyan MohapatraSuresh B. Pakala Review 08 August 2024 Article: 221
Doxorubicin downregulates cell cycle regulatory hub genes in breast cancer cells Mano Chitra KarthikeyanChandhru SrinivasanAntony Joseph Velanganni Arockiam Original Article 08 August 2024 Article: 220
Cabazitaxel as a promising therapy for cisplatin-resistant bladder cancer: a preliminary study Asim JoshiAbantika GhoshPrashant Kumar Original Paper 06 August 2024 Article: 219
Comment on “Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi-receptor approach for potential therapeutic agents in colorectal cancer” YuHan WangYaLing LiJun Li Comment 05 August 2024 Article: 216
Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay Hanan ElimamSherif S. Abdel MageedAhmed S. Doghish Review 05 August 2024 Article: 218
Tetrahydroisoquinoline reduces angiogenesis by interacting myeloma cells with HUVECs mediated by extracellular vesicles Ahmad KooshariFahimeh ShahriyaryMohammad Reza Amirzargar Original Paper 05 August 2024 Article: 217
Comment on ‘Therapeutic targeting of TNIK in papillary thyroid carcinoma: a novel approach for tumor growth suppression’ Nilina James Comment 01 August 2024 Article: 215
Targeted gene therapy for cancer: the impact of microRNA multipotentiality Nourhan A. Abou MadawiZeinab E. DarwishEnas M. Omar Review Article Open access 01 August 2024 Article: 214
Correction to: Auraptene‑induced cytotoxic effects in acute myeloid leukemia cell Lines Majid GhorbaniMohammad SoukhtanlooMohammad Hadi Sadeghian Correction 30 July 2024 Article: 213
